Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
bioRxiv (2021) - Comments
doi: 10.1101/2021.10.06.21264648 

Tom M. Quinn, Erin E. Gaughan, Annya Bruce, Jean Antonelli, Richard O’Connor, Feng Li, Sarah McNamara, Oliver Koch, Claire MacIntosh, David Dockrell, Timothy Walsh, Kevin G. Blyth, Colin Church, Jürgen Schwarze, Cecilia Boz, Asta Valanciute, Matthew Burgess, Philip Emanuel, Bethany Mills, Giulia Rinaldi